炎症性肠病13例血栓并发症临床特点分析附视频

被引:14
作者
董旭暘
吕红
陈轩馥
李骥
李玥
谭蓓
舒慧君
张慧敏
钱家鸣
杨红
机构
[1] 中国医学科学院北京协和医学院北京协和医院消化科
关键词
炎症性肠病; 溃疡性结肠炎; 克罗恩病; 血栓事件;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
100201 [内科学];
摘要
目的分析炎症性肠病(IBD)患者发生血栓的临床特点,提高对这部分疾病人群的认识。方法检索2005年1月至2015年12月在北京协和医院住院诊治的IBD患者,筛选出其中明确出现血栓事件的患者进行回顾性研究,以1∶5选取同时期就诊、相同疾病分型、性别、年龄相匹配的无血栓事件IBD患者连续入组作为对照组,记录一般情况、IBD的分型及活动度、血栓事件的相关症状、发生部位、诱因、治疗及转归,并进行比较分析。结果共检索到IBD患者1521例,出现血栓事件者13例,血栓事件的总体发生率为0.85%。其中溃疡性结肠炎(UC)和克罗恩病(CD)患者中血栓事件发生率分别为0.93%和0.76%。血栓组男6例,女7例;平均年龄(44.3±10.7)岁。76.9%的患者为下肢深静脉血栓,表现为下肢非对称性水肿。1例CD患者出现下肢动脉血栓,表现为下肢坏疽。血栓组53.8%的患者在发现血栓时处于疾病重度活动期,与对照组相比差异有统计学意义(P=0.048)。血栓组患者中76.9%的患者在发生血栓前30 d内使用过糖皮质激素,明显高于对照组(29.2%)(P=0.003)。抗凝治疗以低分子肝素及华法林为主。2例患者治疗后血栓溶解吸收,其余患者复查均提示血栓再通。结论血栓栓塞是IBD患者的重要并发症,多出现于疾病活动期,常见部位为下肢深静脉血栓。糖皮质激素可能是常见诱因。抗凝治疗有效且相对安全。
引用
收藏
页码:213 / 216
页数:4
相关论文
共 7 条
[1]
Increased Risk of Venous Thromboembolic Events With Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease[J] Peter D.R. Higgins;Martha Skup;Parvez M. Mulani;Jay Lin;Jingdong Chao Clinical Gastroenterology and Hepatology 2015,
[2]
Procoagulatory State in Inflammatory Bowel Diseases Is Promoted by Impaired Intestinal Barrier Function[J] Luca Pastorelli;Elena Dozio;Laura Francesca Pisani;Massimo Boscolo-Anzoletti;Elena Vianello;Nadia Munizio;Luisa Spina;Gian Eugenio Tontini;Flora Peyvandi;Massimiliano Marco Corsi Romanelli;Maurizio Vecchi;Gerassimos Mantzaris Gastroenterology Research and Practice 2015,
[3]
Consensus Statements on the Risk; Prevention; and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology[J] Geoffrey C. Nguyen;Charles N. Bernstein;Alain Bitton;Anthony K. Chan;Anne M. Griffiths;Grigorios I. Leontiadis;William Geerts;Brian Bressler;J. Decker Butzner;Marc Carrier;Nilesh Chande;John K. Marshall;Chadwick Williams;Clive Kearon Gastroenterology 2014,
[4]
Meta‐analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease[J] H. Yuhara;C. Steinmaus;D. Corley;J. Koike;M. Igarashi;T. Suzuki;T. Mine Aliment Pharmacol Ther 2013,
[5]
Clinical presentation of venous thromboembolism in inflammatory bowel disease[J] Pavol Papay;Wolfgang Miehsler;Herbert Tilg;Wolfgang Petritsch;Walter Reinisch;Andreas Mayer;Thomas Haas;Arthur Kaser;Thomas Feichtenschlager;Harry Fuchssteiner;Peter Knoflach;Harald Vogelsang;Reingard Platzer;Wolfgang Tillinger;Bernhard Jaritz;Alfons Schmid;Benedikt Blaha;Clemens Dejaco;Anna Sobala;Ansgar Weltermann;Sabine Eichinger;Gottfried Novacek Journal of Crohn's and Colitis 2012,
[6]
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study[J] Matthew J Grainge;Joe West;Timothy R Card The Lancet 2010,
[7]
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting[J] Liam Smeeth;Claire Cook;Sara Thomas;Andrew J Hall;Richard Hubbard;Patrick Vallance The Lancet 2006,